Addiction Cue-Reactivity Initiative (ACRI) Network , Sangchooli A, Zare-Bidoky M, Fathi Jouzdani A, Schacht J, Bjork JM, Claus ED, Prisciandaro JJ, Wilson SJ, Wüstenberg T, Potvin S, Ahmadi P, Bach P, Baldacchino A, Beck A, Brady KT, Brewer JA, Childress AR, Courtney KE, Ebrahimi M, Filbey FM, Garavan H, Ghahremani DG, Goldstein RZ, Goudriaan AE, Grodin EN, Hanlon CA, Haugg A, Heilig M, Heinz A, Holczer A, van Holst RJ, Joseph JE, Juliano AC, Kaufman MJ, Kiefer F, Khojasteh Zonoozi A, Kuplicki RT, Leyton M, London ED, Mackey S, McClernon FJ, Mellick WH, Morley K, Noori HR, Oghabian MA, Oliver JA, Owens M, Paulus MP, Perini I, Rafei P, Ray LA, Sinha R, Smolka MN, Soleimani G, Spanagel R, Steele VR, Tapert SF, Vollstädt-Klein S, Wetherill RR, Witkiewitz K, Yuan K, Zhang X, Verdejo-Garcia A, Potenza MN, Janes AC, Kober H, Zilverstand A, Ekhtiari H. Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review. JAMA Psychiatry. 2024 81(4):414-425. Epub 2024 Feb 7.
Amunts K, Axer M, Banerjee S, Bitsch L, Bjaalie J. G., Brauner P, Brovelli A., Calarco N, Carrere M, Caspers S, Charvet C, Cichon S, Cools R, Constantini I, D'Angelo E, De Bonis G, Deco G, DeFelipe J, Destexhe A, Dickscheid T, Diesmann M, Düzel E, Eickhoff SB, Einevoll GT, Eke D, Engel A, Evans AC, Evers K, Fedorchenko N, Forkel S J, Fousek J, Friederici AD, Friston K, Furber S, Geris L, Göbel RW, Güntürkün O, Abd Hamid A I, Herold CJ, Hilgetag C C, Hölter SM, Ioannidis Y, Jirsa V, Kashyap S, Kasper B S, de Kerchove d'Exaerde A, Kooijmans R, Koren I, Hellgren Kotaleski J, Kiar G, Klijn W, Klüver L, Knoll A C, Krsnik Z, Kämpfer J, Larkum ME, Linne ML, Lippert T, Abdullah J M, Di Maio P, Magielse N, Maquet P, Mascaro A L A, Marinazzo D, Mejias JF, Meyer-Lindenberg A, Migliore M, Michael J, Morel Y, Morin F O, Muckli L, Nagels G, Oden L, Palomero-Gallagher N, Panagiotaropoulos F, Paolucci P S, Pennartz CMA, Peeters L M, Petkoski S, Petkov N, Petro L S, Petrovici M A, Pezzulo G, Roelfsema P, Ris L, Ritter P, Rockland K, Rotter S, Rowald A, Ruland S, Ryvlin P, Salles A, Sanchez-Vives M V, Schemmel J, Senn W, de Sousa A A, Ströckens F, Thirion B, Uludag K, Vanni S, van Albada S J, Vanduffel W, Vezoli J, Vincenz-Donnelly L, Walter F, Zaborszky L. The coming decade of digital brain research: a vision for neuroscience at the intersection of technology and computing. Imaging Neurosci. 2024 2
Bach P, Zaiser J, Vetter S, Gessner T, Hoffmann S, Gerhardt S, Berhe O, Bekier N, Abel M, Radler P, Langejürgen J, Tost H, Lenz B, Vollstädt-Klein S, Stallkamp J, Kirschbaum C, Kiefer F. Stress-induced sensitization of insula activation predicts alcohol craving and alcohol use in alcohol use disorder. Biol Psychiatry. 2024 95(3):245-255. Epub 2023 Sep 9.
Borruto AM, Calpe-López C, Spanagel R, Bernardi R. Conditional Deletion of the AMPA-GluA1 and NMDA-GluN1 Receptor Subunit Genes in Midbrain D1 Neurons does not Alter Cocaine Reward in Mice. Neuropharmacology. 2024 258:110081. Epub 2024 Jul 11.
Bougelet E, Deffaa M, Türkmen C, Kiefer F, Vollstädt-Klein S, Gerhardt S. The Role of Perceived Stress in the Relation between Childhood Maltreatment and Severity of Alcohol Use Disorder: A Mediation Analysis. Eur Addict Res. 2024 30(6):347-356. Epub 2024 Jul 17.
Ersche KD. Defending and defining compulsive behaviour in addiction. Addict Biol. 2024 29(8):e13427.
Ersche KD, Stochl J, Brühl AB, Gurnell M. Evidence of Hypothalamic-Pituitary-Adrenal and -Gonadal Dysfunction in Cocaine-Addicted Men. Eur Addict Res. 2024 30(2):114-120. Epub 2024 Jan 12.
Fernando J, Ersche KD. Mismatch of Biological and Social Time in Cocaine-Addicted Men. Eur Addict Res. 2024 30(1):23-31. Epub 2023 Dec 11.
Foo JC, Völker MP, Streit F, Frank J, Zacharias N, Zillich L, Sirignano L, Nürnberg P, Wienker TF, Wagner M, Nöthen MM, Nothnagel M, Walter H, Lenz B, Spanagel R, Kiefer F, Winterer G, Rietschel M, Witt SH. Polygenic risk scores for nicotine use and family history of smoking are associated with smoking behaviour. Drug Alcohol Depend. 2024 263:112415. Epub 2024 Aug 15.
Frischknecht U, Pätz T, Riegler A, Reinhard I, Kiefer F, Hermann D, Weber T. Raucherbezogenes Selbststigma als Prädiktor für die Teilnahme an einem Tabakentwöhnungsprogramm während einer stationären Qualifizierten Entzugsbehandlung und dessen Erfolg. Suchttherapie. 2024 25(4):191-197.
Gerlach B, Meinhardt M, Kas MJH. Implementation of the EQIPD Quality System. J Neurosci Methods. 2024 405:110084. Epub 2024 Feb 23.
Guiraud J, Spanagel R, van den Brink W. Substitution therapy for patients with alcohol dependence: Mechanisms of action and efficacy. Int Rev Neurobiol. 2024 175:187-239.
Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt M, Bernhardt N. Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction. Transl Psychiatry. 2024 14(1):486.
Hartnagel LM, Emden D, Foo JC, Streit F, Witt SH, Frank J, Limberger MF, Schmitz SE, Gilles M, Rietschel M, Hahn T, Ebner-Priemer U, Sirignano L. Momentary Depression Severity Prediction in Patients With Acute Depression Who Undergo Sleep Deprivation Therapy: Speech-Based Machine Learning Approach. JMIR Ment Health. 2024 11:e64578.
Heesen SH, Köhr G. GABAergic interneuron diversity and organization are crucial for the generation of human-specific functional neural networks in cerebral organoids. Front Cell Neurosci. 2024 18:1389335.
Heinz A, Gutwinski S, Bahr NS, Spanagel R, Di Chiara G. Does compulsion explain addiction?. Addict Biol. 2024 29(4):e13379.
Hoffmann S, Gerhardt S, Mühle C, Reinhard I, Reichert D, Bach P, Boroumand-Jazi R, Kuehner C, Aguilera A, Aslan A, Bahr NS, Belanger M, Deeken F, Ebrahimi C, Fischbach PC, Ganz M, Garbusow M, Großkopf CM, Heigert M, Hentschel A, Karl D, Liu S, Mazza M, Pelz P, Pinger M, Reichl MR, Riemerschmid C, Rosenthal A, Steffen J, Strehle J, Wedemeyer F, Weiß F, Wenzel J, Wieder G, Wieland A, Zaiser J, Zech HG, Vetter S, Kornhuber J, Müller CP, Sommer WH, Spanagel R, Banaschewski T, Deserno L, Ebner-Priemer UW, Flor H, Kirsch P, Rietschel M, Vollstädt-Klein S, Walter H, Meyer-Lindenberg A, Rapp MA, Witt S, Smolka MN, Heinz A, Tost H, Kiefer F, Reichert M, Lenz B, ReCoDe Consortium . Associations of Menstrual Cycle and Progesterone-to-Estradiol Ratio With Alcohol Consumption in Alcohol Use Disorder: A Sex-Separated Multicenter Longitudinal Study. Am J Psychiatry. 2024 181(5):445-456. Epub 2024 Jan 10.
Iorgu AM, Vasilescu AN, Pfeiffer N, Spanagel R, Mallien A, Inta D, Gass P. Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesions. Eur Arch Psychiatry Clin Neurosci. 2024 274(4):1013-1019. Epub 2023 Nov 7.
Kalinichenko LS, Kohl Z, Mühle C, Hassan Z, Hahn A, Schmitt EM, Macht K, Stoyanov L, Moghaddami S, Bilbao R, Eulenburg V, Winkler J, Kornhuber J, Müller CP. Sex-specific pleiotropic changes in emotional behavior and alcohol consumption in human α-synuclein A53T transgenic mice during early adulthood. J Neurochem. 2024 168(3):269-287.
Kalinichenko LS, Kornhuber J, Sinning S, Haase J, Müller CP. Serotonin Signaling through Lipid Membranes. ACS Chem Neurosci. 2024 15(7):1298-1320.
Kiefer F. [The challenge of drugs: a dynamic situation requires evidence-based interventions]. Nervenarzt. 2024 95(9):779-780.
Müller CP, Yang Y, Singh D, Lenz B, Müller E. [Kratom-From natural remedy to addictive drug and back]. Nervenarzt. 2024 95(9):824-829. Epub 2024 Jul 31.
Nestor LJ, Ersche KD. Gut Hormones: Possible Mediators of Addictive Disorders?. Eur Addict Res. 2024 30(6):339-346. Epub 2024 Oct 10.
Nestor LJ, Luijten M, Ziauddeen H, Regenthal R, Sahakian BJ, Robbins TW, Ersche KD. The modulatory effects of atomoxetine on aberrant connectivity during attentional processing in cocaine use disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 9(3):314-325. Epub 2023 Aug 21.
Nestor LJ, Vei Lim T, Robbins TW, Ersche KD. Reduced brain connectivity underlying value-based choices and outcomes in stimulant use disorder. Neuroimage Clin. 2024 44:103676. Epub 2024 Sep 29.
Pagano R, Salamian A, Zielinski J, Beroun A, Nalberczak-Skóra M, Skonieczna E, Cały A, Tay N, Banaschewski T, Desrivieres S, Grigis A, Garavan H, Heinz A, Brühl R, Martinot JL, Martinot MP, Artiges E, Nees F, Orfanos DP, Poustka L, Hohmann S, Fröhner JH, Smolka MN, Vaidya N, Walter H, Whelan R, IMAGEN consortium* , Kalita K, Bito H, Müller CP, Schumann G, Okuno H, Radwanska K. Correction: Arc controls alcohol cue relapse by a central amygdala mechanism. Mol Psychiatry. 2024 29(1):5. Epub 2022 Dec 5.
Pinger M, Skirke M, Thome J, Sommer WH, Koppe G, Kirsch P. Delay discounting of rewards and losses, alcohol use, and the influence of socioeconomic factors: A cross-sectional online study in frequent drinkers. Alcohol Clin Exp Res (Hoboken). 2024 48(12):2364-2377.
Pohorala V, Kuchar M, Spanagel R, Bernardi RE. Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice. Neuroscience. 2024 559:156-165. Epub 2024 Sep 3.
Rua C, Raman B, Rodgers CT, Newcombe VFJ, Manktelow A, Chatfield DA, Sawcer SJ, Outtrim JG, Lupson VC, Stamatakis EA, Williams GB, Clarke WT, Qiu L, Ezra M, McDonald R, Clare S, Cassar M, Neubauer S, Ersche KD, Bullmore ET, Menon DK, Pattinson K, Rowe JB. Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations. Brain. 2024 147(12):4121-4130. Epub 2024 Oct 7.
Selim MK, Harel M, De Santis S, Perini I, Sommer WH, Heilig M, Zangen A, Canals S. Repetitive deep TMS in alcohol dependent patients halts progression of white matter changes in early abstinence. Psychiatry Clin Neurosci. 2024 78(3):176-185. Epub 2023 Dec 12.
Spanagel R. How to survive enormous amounts of alcohol. Proc Natl Acad Sci U S A. 2024 121(46):e2420068121.
Türkmen C, Brunborg GS, Lund IO, Kiefer F, Vollstädt-Klein S, Burdzovic Andreas J. Sports participation moderates the risk of family-specific negative life events on alcohol use among adolescents: Evidence from the longitudinal MyLife study. Addict Behav. 2024 155:108041. Epub 2024 Apr 17.
Varga L, Moca VV, Molnár B, Pérez-Cervera L, Selim MK, Díaz-Parra A, Moratal D, Péntek B, Sommer WH, Mureșan RC, Canals S, Ercsey-Ravasz M. Brain dynamics supported by a hierarchy of complex correlation patterns defining a robust functional architecture. Cell Syst. 2024 15(8):770-786.e5.
Wadle LM, Ebner-Priemer U, Foo JC, Yamamoto Y, Streit F, Witt SH, Frank J, Zillich L, Limberger MF, Ablimit A, Schultz T, Gilles M, Rietschel M, Sirignano L. Speech Features as Predictors of Momentary Depression Severity in Patients With Depressive Disorder Undergoing Sleep Deprivation Therapy: Ambulatory Assessment Pilot Study. JMIR Ment Health. 2024 11:e49222.
Wank I, Mittmann C, Kreitz S, Chestnykh D, Mühle C, Kornhuber J, Ludwig A, Kalinichenko LS, Müller CP, Hess A. Neutral sphingomyelinase controls acute and chronic alcohol effects on brain activity. Neuropharmacology. 2024 253:109948. Epub 2024 Apr 16.
Wenger L, Hamm O, Mühle C, Hoffmann S, Reinhard I, Bach P, Kornhuber J, Alpers GW, Kiefer F, Leménager T, Lenz B. Alcohol does not influence trust in others or oxytocin, but increases positive affect and risk-taking: a randomized, controlled, within-subject trial. Eur Arch Psychiatry Clin Neurosci. 2024 274(2):311-320. Epub 2023 Sep 14.
White JD, Minto MS, Willis C, Quach BC, Han S, Tao R, Deep-Soboslay A, Zillich L, Witt SH, Spanagel R, Hansson AC, Clark SL, van den Oord EJ, Hyde TM, Mayfield RD, Webb BT, Johnson EO, Kleinman JE, Bierut LJ, Hancock DB. Alcohol Use Disorder-Associated DNA Methylation in the Nucleus Accumbens and Dorsolateral Prefrontal Cortex. Biol Psychiatry Glob Open Sci. 2024 4(6):100375.
Yang Y, Müller CP, Singh D. Kratom (Mitragyna speciosa) Use and Mental Health: A Systematic Review and Multilevel Meta-Analysis. Eur Addict Res. 2024 30(4):252-274.
Zillich E, Belschner H, Avetyan D, Andrade-Brito D, Martínez-Magaña JJ, Frank J, Mechawar N, Turecki G, Cabana-Domínguez J, Fernàndez-Castillo N, Cormand B, Montalvo-Ortiz JL, Nöthen MM, Hansson AC, Rietschel M, Spanagel R, Witt SH, Zillich L. Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder. Transl Psychiatry. 2024 14(1):428.
Zillich L, Artioli A, Pohorala V, Zillich E, Stertz L, Belschner H, Jabali A, Frank J, Streit F, Avetyan D, Völker M, Müller S, Hansson A, Meyer T, Rietschel M, Spanagel R, Oliveira A, Walss-Bass C, Bernardi R, Koch P, Witt S. Cell type-specific Multi-Omics Analysis of Cocaine Use Disorder in the Human Caudate Nucleus. Res Sq. 2024
Zillich L, Cetin M, Hummel EM, Poisel E, Fries GR, Frank J, Streit F, Foo JC, Sirignano L, Friske MM, Lenz B, Hoffmann S, Adorjan K, Kiefer F, Bakalkin G, Hansson AC, Lohoff FW, Kärkkäinen O, Kok E, Karhunen PJ, Sutherland GT, Walss-Bass C, Spanagel R, Rietschel M, Moser DA, Witt SH. Biological aging markers in blood and brain tissue indicate age acceleration in alcohol use disorder. Alcohol Clin Exp Res (Hoboken). 2024 48(2):250-259.
von Zimmermann C, Hübner M, Mühle C, Müller CP, Weinland C, Kornhuber J, Lenz B. Masculine depression and its problem behaviors: use alcohol and drugs, work hard, and avoid psychiatry!. Eur Arch Psychiatry Clin Neurosci. 2024 274(2):321-333. Epub 2023 Feb 28.